Background: Vitamin D has several roles, namely physiological function of calcium and bone metabolism, cell growth and differentiation, immune and cardiovascular function. Vitamin D deficiency can cause the risk of cancer. Head and neck cancer is one of the cancers that occur due to vitamin D deficiency in the body. This literature review was to asses and evaluate the impact and benefits of vitamin D supplementation for head and neck cancer. Discussion: A study found an association between vitamin D supplementation and a low risk of recurrence in conditions of high total vitamin D levels. Another study found a significant increase in quality of life (QOL). The primary mechanism of vitamin D action is mediated through binding of either 1,25(OH)2D3 (active form) or 25(OH)D (less active form) to the VDR, which is a member of the nuclear receptor superfamily of steroid and thyroid hormones with gene-regulatory and consequent anti-proliferative properties. Conclusions: Vitamin D supplementation provides a role in improving the condition of patients with head and neck cancer. Both in terms of suppressing recurrence and in terms of increasing quality of life
Keywords:
head and neck cancer; quality of life; recurrence; vitamin D
Lips PÃ. Vitamin D physiology. 2006;92:4-8. doi:10.1016/j.pbiomolbio.2006.02.016
Oa L, London P, Commons C, License A. Kingsley K , Bergman C , Keiserman M , Mobley C . Oral cancer risk and vitamin D status , intake , and supplementation : A review . OA. 2013;1(1).
Maria S, Ferreira S, Henrique M, et al. Prevalence of hypovitaminosis D and its association with oral lesions in HIV-infected Brazilian adults. Rev Soc Bras Med Trop. 2016;49(1):90-94.
Orkin C, Wohl DA, Williams A, Deckx H. Vitamin D Deficiency in HIV : A Shadow on Long-Term Management ? AIDS Rev. 2014:59-74.
Lopiccolo MC, Lim HW. Vitamin D in health and disease. 2010;2:224-229.
Lake J, Adam J. Vitamin D in HIV-Infected Patients. NIH Public Access. 2011;8(3):133-141. doi:10.1007/s11904-011-0082-8.Vitamin
Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Publ Gr. 2014;14(5):342-358. doi:10.1038/nrc3691
Vashi PG, Trukova K, Lammersfeld CA, Braun DP, Gupta D. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J. 2010;9(1):60. doi:10.1186/1475-2891-9-60
Garland CF, Garland FC, Gorham ED, et al. The Role of Vitamin D in Cancer Prevention. 2006;96(2):252-261. doi:10.2105/AJPH.2004.045260
Anand A, Singh S, Sonkar AA, Husain N. Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment. Contemp Oncol. 2017;21(2):145-151.
Grimm M, Cetindis M, Biegner T, Lehman M, Munz A, Teriete P. Serum vitamin D levels of patients with oral squamous cell carcinoma ( OSCC ) and expression of vitamin D receptor in oral
precancerous lesions and OSCC. 2015;20(2). doi:10.4317/medoral.20368
Zeljic K, Supic G, Radak MS, Jovic N, Kozomara R. Vitamin D receptor , CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. 2012. doi:10.1111/j.1600-0714.2012.01164.x
Tran HUY, Pant R, Adams JS, Mallya SM. Vitamin D signaling regulates oral keratinocyte proliferation in vitro and in vivo. 2014;(11):1625-1633. doi:10.3892/ijo.2014.2338
Sundaram K, Sambandam Y. 1 α , 25-Dihydroxyvitamin D3 Modulates CYP2R1 Gene Expression in Human Oral Squamous Cell Carcinoma Tumor Cells. 2014;3. doi:10.1007/s12672-014-0170-5
Trump, Donald L, Deeb, Kristen, Johnson CS. Vitamin d: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy. 2010:1-9.
Adeyemi OM, Agniel D, French AL, et al. Vitamin D Deficiency in HIV-Infected and HIV-Uninfected Women in the United States. Jaids-Journal Acquir Immune Defic Syndr. 2011;57(3):197-204. doi:10.1097/QAI.0b013e31821ae418
Kotikangas HO, Schwab U, Pia O. High Prevalence of Vitamin D Insufficiency in Patients with Head and Neck Cancer at Diagnosis. 2012:1-7. doi:10.1002/hed
Yokosawa EB, Arthur AE, Rentschler KM, Wolf GT, Rozek LS, Mondul AM. Vitamin D Intake and Survival and Recurrence in Head and Neck Cancer Patients. 2018;25:1-6. doi:10.1002/lary.27256
Fleet JC. Molecular Actions of Vitamin D Con tributing to Cancer Prevention. Mol Asp Med. 2008;29(6):388-396. doi:10.1016/j. mam.2008.07.003.Molecular
Roh J, Park J, Park C Il. Prevention of Postoperative Hypocalcemia With Routine Oral Calcium and Vitamin d Supplements in Patients With Differentiated Papillary Thyroid Carcinoma Undergoing Total Thyroidectomy Plus Central Neck Dissection. 2009. doi:10.1002/cncr.24027
Walsh, Jarret E et al. Use of Alpha, 25 Dihydroxyvitamin D3 Treatment to Stimulate Immune Infiltration Into Head and Neck Squamous Cell Carcinoma. Hum Immunol. 2010;71(7):659-665. doi:10.1016/j.humimm.2010.04.008.Use
Wang L, Wang C, Wang J, Huang X, Cheng Y. Longitudinal , observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Nat Publ Gr. 2016;(August):1-10. doi:10.1038/srep38962
Xu W, Adjei A, Bairati I, Liu G, Douville P. Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. doi:10.1002/ijc.25496
Lipworth L, Rossi M, Mclaughlin JK, et al. original article Dietary vitamin D and cancers of the oral cavity and esophagus. 2009:1576-1581. doi:10.1093/annonc/mdp036
Holick MF, Chen TC. Vitamin D defciency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S-6S. doi:87/4/1080S [pii]